date,title,source
Oct-24-18,"Report: Developing Opportunities within Univar, Aqua America, Chimerix, Superior Energy Services, TechTarget, and ZIOPHARM Oncology  Future Expectations, Projections Moving into 2018",GlobeNewswire
Oct-26-18,Implied Volatility Surging for ZIOPHARM Oncology (ZIOP) Stock Options,Zacks
Oct-29-18,Ziopharm Oncology (ZIOP) Q3 Earnings Preview: What's Shaping Up?,Zacks
Oct-31-18,"Ziopharm Oncology to Announce Third Quarter 2018 Financial Results, Host Conference Call Nov. 8",GlobeNewswire
Nov-05-18,Ziopharm Oncology to Present Update on Controlled IL-12 Brain Cancer Trial at Annual Meeting of the Society for Neuro-Oncology on Nov. 16,GlobeNewswire
Nov-07-18,Ziopharm Oncology to Present at the Stifel 2018 Healthcare Conference on Nov. 14,GlobeNewswire
Nov-08-18,Ziopharm Oncology Third Quarter 2018 Financial Results Conference Call Rescheduled to Nov. 12,GlobeNewswire
Nov-09-18,Intrexon (XON) Reports Narrower-Than-Expected Loss in Q3,Zacks
Nov-12-18,Edited Transcript of ZIOP earnings conference call or presentation 12-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-12-18,Ziopharm Oncology to Host Conference Call Today at 8 a.m.,GlobeNewswire
Nov-12-18,Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer,GlobeNewswire
Nov-12-18,Ziopharm Oncology Announces $50 Million Private Placement,GlobeNewswire
Nov-13-18,"Ziopharm Oncology (ZIOP) Reports Q3 Loss, Lags Revenue Estimates",Zacks
Nov-14-18,"Biotech Stock Roundup: Gilead, Regeneron Present Data, Cocrystal Pharma Surges",Zacks
Nov-16-18,Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology,GlobeNewswire
Nov-16-18,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",Benzinga
Nov-29-18,Are Options Traders Betting on a Big Move in ZIOPHARM Oncology (ZIOP) Stock?,Zacks
Dec-03-18,Edited Transcript of ZIOP earnings conference call or presentation 12-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Dec-03-18,"Market Trends Toward New Normal in Zillow Group, YRC Worldwide, The Home Depot, UROGEN PHARMA, ZIOPHARM Oncology, and Cinedigm  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-04-18,Edited Transcript of ZIOP earnings conference call or presentation 12-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Dec-13-18,Ziopharm Oncology Promotes Dr. David Mauney to President,GlobeNewswire
Dec-14-18,"The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch",Benzinga
Dec-19-18,"Ziopharm Oncology and TriArm Therapeutics Establish Joint Venture to Develop and Commercialize Sleeping Beauty CAR T in China, Taiwan and Korea",GlobeNewswire
Dec-21-18,Is the Options Market Predicting a Spike in Ziopharm Oncology (ZIOP) Stock?,Zacks
Dec-21-18,Ziopharm Oncology to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Dec-27-18,Ziopharm Oncology Responds to Recent Stock Decline and Clarifies Exclusivity Rights for Clinical Assets,GlobeNewswire
Dec-27-18,4 Healthcare Stocks That Could Test December Highs,ACCESSWIRE
Dec-28-18,Ziopharm Oncology (ZIOP) in Focus: Stock Moves 6.2% Higher,Zacks
Jan-07-19,Ziopharm Oncology Posts Letter to Stockholders,GlobeNewswire
Feb-01-19,"The Unknown Biotech Play that Could Deliver 400% Returns, or Much More",ACCESSWIRE
Feb-11-19,Ziopharm Oncology Completes Enrollment of Controlled IL-12 Monotherapy Expansion Substudy in Phase 1 Brain Cancer Trial,GlobeNewswire
Feb-13-19,"Is ZIOPHARM Oncology, Inc.s (NASDAQ:ZIOP) CEO Paid At A Competitive Rate?",Simply Wall St.
Feb-14-19,"Recent Analysis Shows Lattice Semiconductor, ZIOPHARM Oncology, Ferro, SYNNEX, AxoGen, and Twin Disc Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Feb-21-19,Ziopharm Oncology CEO to Present at the CAR-TCR Summit Europe,GlobeNewswire
Feb-25-19,Ziopharm Oncology to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 5,GlobeNewswire
Mar-01-19,Intrexon (XON) Reports Narrower-Than-Expected Loss in Q4,Zacks
Mar-05-19,Ziopharm Oncology Inc (ZIOP) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Mar-05-19,Ziopharm Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Mar-06-19,Edited Transcript of ZIOP earnings conference call or presentation 5-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
Apr-01-19,Ziopharma's Lead Asset Snags Fast Track Designation For Cancer Treatment,Benzinga
Apr-01-19,Ziopharm Oncology Announces FDA Fast Track Designation for Ad-RTS-hIL-12 plus Veledimex for the Treatment of Recurrent Glioblastoma,GlobeNewswire
Apr-16-19,"What Kind Of Shareholder Appears On The ZIOPHARM Oncology, Inc.'s (NASDAQ:ZIOP) Shareholder Register?",Simply Wall St.
Apr-25-19,Edited Transcript of ZIOP earnings conference call or presentation 5-Mar-19 9:30pm GMT,Thomson Reuters StreetEvents
May-01-19,"Ziopharm Oncology to Host Conference Call to Discuss First Quarter 2019 Financial Results on May 8, 2019",GlobeNewswire
